• 52,738+ CME Conference Registrations Sold
  • 158,215+ Medical Conferences
  • 285 Specialties
  • 11,420 Organizers
  • 157,118 Speakers
  • 159 Countries
  • 4,801 Cities
Home  >  Speakers  >  Brad J. Loncar
Brad J. Loncar

Brad J. Loncar

Founder, Chief Executive Officer | Lenexa, Kansas    United States of America
Biotechnology, Cancer Immunotherapy
Spoken at 2 events

Biography :

Brad Loncar is an independent biotech investor and analyst and has managed a biotech-focused family office since 2008. Through Loncar Investments LLC, he uses his research of biotech companies and technologies to develop thematic biotech investment indexes. The Loncar Cancer Immunotherapy Index was launched in March of 2015. It is the only of its kind and consists of 30 companies leading the way in the emerging field of cancer immunotherapy. Mr. Loncar previously worked at Franklin Templeton Investments and served in a Senior Advisor role at the U.S. Department of the Treasury. He is one of the most followed biotech commentators on social media and writes a biotech commentary at www.LoncarBlog.com. He holds a BA in Finance from the University of Miami.

For speaker's contact information - Contact us



Interested Topics

Biotechnology, Cancer Immunotherapy

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message

Live to Virtual Conference

Market your online event to Million plus Healthcare professionals.